GLP-1 RAs Linked to Lower Mortality, Amputation Risk in PAD and Type 2 Diabetes

July 6, 2026—Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, amputation, and lower-extremity revascularization compared with metformin among adults with type 2 diabetes and peripheral artery disease (PAD), according to the American Heart Association.

DETOUR2 Evaluates PTAB With Endologix Detour System in Complex SFA Disease at 3 Years

July 8, 2026—Endologix LLC announced 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass (PTAB) using the company’s Detour system.

Shape Memory Medical’s Pivotal AAA SHAPE Trial Completes Enrollment

July 8, 2026—Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolization, announced that it has completed enrollment in the AAA SHAPE pivotal trial of the company’s investigational Impede FX RapidFill device.

Penumbra Begins FORWARD Study of Red Perfusion Catheter Portfolio in Distal Acute Ischemic Stroke Management

July 7, 2026—Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical thrombectomy in the management of acute ischemic stroke with distal occlusions.

FDA Approves Updated Labeling of Gore Excluder EVAR Devices for Ruptured AAAs

July 7, 2026—Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) endoprosthesis and Gore Excluder Conformable AAA endoprosthesis, adding real-world clinical evidence that supports the use of endovascular aneurysm repair (EVAR) devices in appropriately selected patients with ruptured AAAs (rAAAs).

Egg Medical Launches EggNest Complete 2.0 Radiation Protection Device

July 6, 2026—Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch of its next-generation EggNest Complete 2.0 system.

Arizona Enacts Law on Radiation Protection Systems for Health Care Workers

July 6, 2026—A state law addressing the safety of staff in medical procedures involving ionizing radiation, lead aprons, radiation protection systems, and real-time dosimeters was enacted by Arizona Governor Kathy Hobbs on June 19.

First Patient Enrolled in DEEPER CHALLENGE Trial of Reflow Spur in Select CLTI Cohort

July 2, 2026—Reflow Medical, Inc. announced the enrollment of the first patient in the DEEPER CHALLENGE clinical trial, which is investigating early vessel recoil after below-the-knee treatment using the company’s Spur peripheral retrievable scaffold system in combination with a commercially available drug-coated balloon.